Blockchain Registration Transaction Record

Viromed Medical Expands ViroCAP Distribution to Six New Markets

Viromed Medical AG signs distribution partnerships for ViroCAP in Spain, Portugal, Greece, Balkans, Romania, Saudi Arabia, expecting 3,000+ device sales annually.

This expansion signifies a major step for Viromed Medical in establishing a global footprint for cold plasma technology. For healthcare providers in the new markets, it means access to an innovative, non-invasive treatment for skin conditions, potentially improving patient outcomes. For the company, it diversifies revenue streams and strengthens its position in the medical device industry, signaling growth and investment opportunities. For the broader healthcare ecosystem, it demonstrates the increasing acceptance and commercial viability of cold plasma therapy, which could lead to more widespread adoption and further innovation.